BIIB - Company ID 0000875045
The table below shows BIOGEN INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $2.22B | $2.38B | $1.95B | $2.21B | $2.27B | $2.27B |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $7.58B |
| $7.31B |
| $9.19B |
| $8.94B |
| $7.97B |
| $7.63B |
| Property, plant & equipment | $2.97B | $2.99B | $3.02B | $3.08B | $3.10B | $3.13B |
| Goodwill | $6.99B | $6.99B | $6.49B | $6.49B | $6.49B | $6.48B |
| Total assets | $32.05B | $32.09B | $29.48B | $29.21B | $28.33B | $28.03B |
| Accounts payable | $430.30M | $403.90M | $358.50M | $413.10M | $408.40M | $391.50M |
| Total current liabilities | $3.90B | $3.92B | $3.00B | $3.29B | $3.18B | $5.30B |
| Long-term debt | $7.29B | $7.29B | $6.29B | $6.29B | $6.28B | $4.55B |
| Total liabilities | $13.13B | $13.24B | $10.83B | $11.00B | $10.70B | $11.05B |
| Retained earnings | $20.95B | $20.97B | $20.87B | $20.60B | $20.14B | $19.50B |
| Total equity | - | - | - | - | - | - |